Evidence of apoptosis in arrhythmogenic right ventricular dysplasia

被引:338
|
作者
Mallat, Z
Tedgui, A
Fontaliran, F
Frank, R
Durigon, M
Fontaine, G
机构
[1] HOP LARIBOISIERE,INSERM,U141,F-75475 PARIS,FRANCE
[2] HOP RAY POINCARE,SERV ANAT & CYTOL PATHOL,GARCHES,FRANCE
来源
NEW ENGLAND JOURNAL OF MEDICINE | 1996年 / 335卷 / 16期
关键词
D O I
10.1056/NEJM199610173351604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Arrhythmogenic right ventricular dysplasia, a disorder that may lead to severe ventricular arrhythmias and sudden death, is characterized by the progressive replacement of myocardial cells by fat and fibrous tissue. We examined whether the loss of myocardial cells in this disease could result from cell death by apoptosis (programmed cell death). Methods Specimens obtained at autopsy from the right ventricular myocardium of eight patients with arrhythmogenic right Ventricular dysplasia and four age-matched normal subjects were analyzed. To identify individual cells undergoing apoptosis, we performed in situ end-labeling of fragmented DNA on paraffin sections using biotinylated deoxyuridine triphosphate and the enzyme terminal deoxynucleotidyl transferase, We also examined the level of expression of CPP-32, a cysteine protease required for apoptotic cell death in mammalian cells, using immunohistochemical techniques. Results Apoptosis was detected in the right ventricular myocardium of six of the eight patients with arrhythmogenic right ventricular dysplasia and was absent in the controls, High levels of expression of CPP-32 were associated with positive in situ end-labeling of fragmented DNA. Conclusions These results indicate that apoptotic myocardial cell death occurs in arrhythmogenic right ventricular dysplasia and may contribute to the loss of myocardial cells in this disorder. (C) 1996, Massachusetts Medical Society.
引用
收藏
页码:1190 / 1196
页数:7
相关论文
共 50 条
  • [1] Evidence of apoptosis in arrhythmogenic right ventricular dysplasia.
    Mallat, Z
    Tedgui, A
    Fontaliran, F
    Frank, R
    Durigon, M
    Fontaine, G
    CIRCULATION, 1996, 94 (08) : 2493 - 2493
  • [2] Arrhythmogenic right ventricular dysplasia
    Leenhardt, A.
    Milliez, P.
    Haggui, A.
    Takatsuki, S.
    Hayashi, M.
    Meddane, M.
    Dejode, P.
    Denjoy, I.
    Extramiana, F.
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2006, 99 : 7 - 14
  • [3] Arrhythmogenic right ventricular dysplasia
    Brugada, J
    Mont, L
    Brugada, R
    REVISTA ESPANOLA DE CARDIOLOGIA, 1997, 50 (08): : 541 - 547
  • [4] Arrhythmogenic right ventricular dysplasia
    Fontaine, G
    Fontaliran, F
    Hébert, JL
    Chemla, D
    Zenati, O
    Lecarpentier, Y
    Frank, R
    ANNUAL REVIEW OF MEDICINE, 1999, 50 : 17 - 35
  • [5] Arrhythmogenic right ventricular dysplasia
    Muthappan, Palaniappan
    Calkins, Hugh
    PROGRESS IN CARDIOVASCULAR DISEASES, 2008, 51 (01) : 31 - 43
  • [6] Arrhythmogenic right ventricular dysplasia
    Nikitin, YP
    Lyutova, FF
    Nazarova, OM
    TERAPEVTICHESKII ARKHIV, 1998, 70 (01) : 74 - 76
  • [7] Arrhythmogenic right ventricular dysplasia
    Anderson, EL
    AMERICAN FAMILY PHYSICIAN, 2006, 73 (08) : 1391 - 1398
  • [8] Arrhythmogenic right ventricular dysplasia
    Kinsara, AJ
    Zaman, L
    Gorgels, A
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2001, 19 (01): : 67 - 70
  • [9] Arrhythmogenic right ventricular dysplasia
    Richard G. Trohman
    Jonathan Sahu
    Current Treatment Options in Cardiovascular Medicine, 1999, 1 (3) : 259 - 268
  • [10] Arrhythmogenic right ventricular dysplasia
    Patel H.C.
    Calkins H.
    Current Treatment Options in Cardiovascular Medicine, 2010, 12 (6) : 598 - 613